Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.74 | -18.94 |
PEG Ratio (TTM) | -0.17 | -5.61 |
P/S Ratio (TTM) | 664.40 | 47.90 |
P/B Ratio (TTM) | 12.10 | 30.89 |
P/FCF Ratio (TTM) | -3.90 | -6.05 |
Price to 5YR AVG Earnings Ratio | -8.79 | -5.69 |
Price to 5YR AVG FCF Ratio | -10.89 | -13.62 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -52.60% | -17.89% |
ROE (TTM) | -206.69% | 28.85% |
Net Profit Margin (TTM) | -16,882.37% | -540.96% |
ROIC 5YR AVG | -79.78% | -3.04% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -34.78% | -100.46% | -95.50% |
Revenue | -44.49% | 28.39% | -2.88% |
Net Income | -12.90% | -105.43% | -104.93% |
Cash Flow | -97.20% | -18.38% | -53.79% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.74 | 5.75 |
Quick Ratio (TTM) | 6.74 | 5.53 |
D/E Ratio (TTM) | 2.12 | 1.08 |
Interest Coverage (TTM) | -18.58 | -7.40 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 13.03 |
LTL to 5YR AVG FCF | -2.33 | 0.08 |
Shares Outstanding Growth 5YR AVG | 5.07% | 40.65% |